| Enter Sweepstakes! · Advertise on this site · Get Bargains | |||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
![]() |
|||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||
Heparin and HirudinDateline: 08/07/00 By Alan Bruzel Origins of Heparin and Hirudin These are anticoagulant drugs, each originally isolated from natural sources: heparin from liver (hence its name), and hirudin from the medicinal leech, Hirudo medicinalis. Today, the inner lining of the small intestine of pigs provides the raw material for heparin manufacture. The hirudin gene has been cloned; thus biotechnology, not a leech farm, is the source of hirudin. Biochemistry of Heparin and Hirudin The paragraph above provides a hint as to how these bioactive substances differ. Hirudin has been cloned; heparin has not. In cloning, one places a foreign gene into a host organism, usually a bacterial cell. The host organism grows and reproduces and, most importantly, replicates the foreign gene so that each of its descendants (and their descendants, and so on) receives a copy of the foreign gene. Feeding a specific inducer to these host organisms stimulates the foreign gene to direct the synthesis of its particular product (in this case, a protein), which is then purified and marketed. Recombinant DNA technology is able to prepare hirudin because hirudin is a single protein originating from a single gene. Heparin, however, is a complex carbohydrate, and its synthesis requires the precisely ordered activities of many genes, a technique presently beyond the reach of biotechnology enterprises. Heparin is built from alternating amino sugars and sugar acids that have varying degrees of sulfation. The following diagram illustrates only a portion of the heparin molecule. Natural heparin contains polymer chains ranging in size from 3000 up to 100,000 daltons.
Hirudin is a smaller molecule than heparin, having 65 amino acids and a size of approximately 7000 daltons. Its hydrophobic amino (NH2) end is constrained by intramolecular disulfide bridges; the carboxy (COOH) end of the molecule is more hydrophilic.
Heparin and Hirudin Prevent Blood Clotting Each of these molecules prevents a blood protein, thrombin, from cleaving fibrinogen to fibrin. (Clots are formed when fibrin monomers polymerize. By interfering with the activity of thrombin, one stops blood clots from forming.) Hirudin binds directly to thrombin and inactivates it. Heparin takes a more roundabout approach by binding to another blood protein, antithrombin III. The heparin-antithrombin III complex then binds strongly to thrombin, inactivating it. What the Web Has to Say about: Antithrombotic
Therapy Celsus Laboratories Feinchemie
GmbH Sebnitz Guide
to Anticoagulant Therapy Part 1: Heparin Hemostasis and
Thrombosis Center Heparan
sulfate and heparin Heparinization Hirudin Neoparin
Inc. Pork
By-Products Review of the
Pharmacology, Clinical Applications, and Toxicology of Hirudin and Hirulog
|
|
||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||
|
||||||||||||||||||||